{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Ovid Therapeutics Inc."},"Symbol":{"label":"Symbol","value":"OVID"},"Address":{"label":"Address","value":"1460 BROADWAY,SUITE 15021 14TH FLOOR, NEW YORK, New York, 10036, United States"},"Phone":{"label":"Phone","value":"+1 646 661-7661"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life."},"CompanyUrl":{"label":"Company Url","value":"https://www.ovidrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jeremy Max Levin","title":"Chairman & Chief Executive Officer"},{"name":"Julia Tsai","title":"Senior VP-Clinical Development & Medical Affairs"},{"name":"Manoj Malhotra","title":"Chief Medical Officer"},{"name":"Zhong Zhong","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}